Olivia Fromigué

ResearcherID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 5

Top Venues

Cancers

Cancer research

This page only lists publications with an associated author ORCID identifier.

Publications

Antonin Marchais, Maria Eugénia Marques da Costa, Bastien Job, Rachid Abbas, Damien Drubay, Sophie Piperno-Neumann, Olivia Fromigué, Anne Gomez-Brouchet, Françoise Redini, Robin Droit, Cyril Lervat, Natacha Entz-Werle, Hélène Pacquement, Catherine Devoldere, Didier Cupissol, Damien Bodet, Virginie Gandemer, Marc Berger, Perrine Marec-Berard, Marta Jimenez, Gilles Vassal, Didier Frappaz, Laurence Brugières, Nathalie Gaspar
Immune Infiltrate and Tumor Microenvironment Transcriptional Programs Stratify Pediatric Osteosarcoma into Prognostic Groups at Diagnosis. Cancer research 82 (6) (2022)
Bojana Stefanovska, Fabrice André, Olivia Fromigué
Tribbles Pseudokinase 3 Regulation and Contribution to Cancer. Cancers 13 (8) (2021)
Adèle Mangelinck, Nadia Habel, Audrey Mohr, Nathalie Gaspar, Bojana Stefanovska, Olivia Fromigué
Synergistic Anti-Tumor Effect of Simvastatin Combined to Chemotherapy in Osteosarcoma. Cancers 13 (22) (2021)
Bojana Stefanovska, Cecile Edith Vicier, Thibault Dayris, Vasily Ogryzko, Veronique Scott, Ibrahim Bouakka, Suzette Delaloge, Anna Rocca, Olivier Trédan, Thomas Bachelot, Fabrice André, Olivia Fromigué
Rapalog-Mediated Repression of Tribbles Pseudokinase 3 Regulates Pre-mRNA Splicing. Cancer research 80 (11) (2020)
Maria Eugénia Marques da Costa, Antonin Marchais, Anne Gomez-Brouchet, Bastien Job, Noémie Assoun, Estelle Daudigeos-Dubus, Olivia Fromigué, Conceição Santos, Didier Frappaz, Nathalie Gaspar
In-Vitro and In-Vivo Establishment and Characterization of Bioluminescent Orthotopic Chemotherapy-Resistant Human Osteosarcoma Models in NSG Mice. Cancers 11 (7) (2019)

Olivia Fromigué.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Olivia Fromigué